Cigna Group (NYSE:CI) Stock Has Consensus Price Target of $338.24 According to Brokerages

Shares of Cigna Group (NYSE:CI – Get Free Report) have been assigned an average rating of “Moderate Buy” from the twenty-three research firms that are covering the stock, MarketBeat reports. Eight research analysts have rated the stock with a hold recommendation and fifteen have assigned a buy recommendation to the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $338.24.

CI has been the subject of a number of recent analyst reports. Raymond James Financial lowered Cigna Group from a “strong-buy” rating to an “outperform” rating and decreased their price target for the company from $350.00 to $320.00 in a research report on Monday, August 3rd. Barclays boosted their price objective on Cigna Group from $304.00 to $310.00 and gave the stock an “equal weight” rating in a report on Friday, July 31st. Evercore started coverage on shares of Cigna Group in a research note on Wednesday, September 9th. They set an “in-line” rating and a $290.00 price objective for the company. Guggenheim boosted their price target on shares of Cigna Group from $338.00 to $361.00 and gave the company a “buy” rating in a report on Friday, July 31st. Finally, Wells Fargo & Company lifted their price objective on shares of Cigna Group from $305.00 to $307.00 and gave the stock an “equal weight” rating in a research report on Friday, July 31st.

Get Our Latest Report on Cigna Group

Insider Activity at Cigna Group

In other news, insider Nicole S. Jones sold 19,436 shares of the business’s stock in a transaction on Tuesday, August 4th. The shares were sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the transaction, the insider directly owned 27,256 shares in the company, valued at $7,530,015.12. The trade was a 41.63% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Everett Neville sold 617 shares of the company’s stock in a transaction on Thursday, September 3rd. The stock was sold at an average price of $284.05, for a total transaction of $175,258.85. Following the completion of the transaction, the insider directly owned 5,053 shares in the company, valued at $1,435,304.65. This trade represents a 10.88% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 22,730 shares of company stock worth $6,293,359. Company insiders own 0.60% of the company’s stock.

Institutional Trading of Cigna Group

Hedge funds and other institutional investors have recently modified their holdings of the company. Evercore Wealth Management LLC lifted its stake in Cigna Group by 2.8% in the first quarter. Evercore Wealth Management LLC now owns 1,301 shares of the health services provider’s stock valued at $347,000 after acquiring an additional 35 shares during the last quarter. Independence Bank of Kentucky boosted its holdings in Cigna Group by 2.6% in the second quarter. Independence Bank of Kentucky now owns 1,483 shares of the health services provider’s stock worth $409,000 after purchasing an additional 37 shares in the last quarter. West Family Investments Inc. increased its position in Cigna Group by 4.2% during the second quarter. West Family Investments Inc. now owns 919 shares of the health services provider’s stock worth $253,000 after buying an additional 37 shares during the last quarter. WPG Advisers LLC increased its position in Cigna Group by 24.5% during the first quarter. WPG Advisers LLC now owns 203 shares of the health services provider’s stock worth $54,000 after buying an additional 40 shares during the last quarter. Finally, Maripau Wealth Management LLC increased its position in Cigna Group by 4.0% during the first quarter. Maripau Wealth Management LLC now owns 1,074 shares of the health services provider’s stock worth $287,000 after buying an additional 41 shares during the last quarter. 86.99% of the stock is currently owned by hedge funds and other institutional investors.

Cigna Group Stock Down 2.5%

NYSE CI opened at $298.20 on Friday. Cigna Group has a 1 year low of $239.51 and a 1 year high of $316.27. The business’s fifty day moving average is $282.65 and its two-hundred day moving average is $281.27.

Cigna Group (NYSE:CI – Get Free Report) last released its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, topping the consensus estimate of $7.60 by $0.18. The company had revenue of $71.56 billion for the quarter, compared to the consensus estimate of $70.14 billion. The business’s revenue was up 6.7% compared to the same quarter last year. During the same period in the prior year, the business earned $7.20 earnings per share. Cigna Group has set its FY 2026 guidance at 30.450- EPS. On average, equities analysts anticipate that Cigna Group will post 30.49 earnings per share for the current fiscal year.

About Cigna Group

(Get Free Report)

The Cigna Group (NYSE: CI) is a global health services company that provides insurance coverage, health care benefits and related services. Its operations are primarily organized through Cigna Healthcare, which offers medical, pharmacy, dental, behavioral health and other benefit programs to employers, government organizations and individuals, primarily in the United States.

The company also operates Evernorth Health Services, a health services platform that includes pharmacy benefit management, specialty pharmacy, care management and health-care delivery capabilities.

Read More

Analyst Recommendations for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.